Quotes 5-day view Delayed Nasdaq
06/29/2022
06/30/2022
07/01/2022
07/05/2022
07/06/2022
Date
186.43(c)
184.36(c)
191.04(c)
193.02(c)
195.245 Last
1 223 271
1 243 710
1 118 163
1 104 083
578 627 Volume
-0.53% -1.11% +3.62% +1.04% +1.15% Change
Estimated financial data (e) (USD)
Sales 2022
5 203 M - -
Net income 2022
449 M - -
Net cash position 2022
557 M - -
P/E ratio 2022
65,9x
Yield 2022
-
Sales 2023
6 027 M - -
Net income 2023
738 M - -
Net cash position 2023
1 628 M - -
P/E ratio 2023
42,3x
Yield 2023
-
Capitalization
30 323 M 30 323 M -
EV / Sales 2022
5,72x
EV / Sales 2023
4,76x
Nbr of Employees
9 825
Free-Float
79,4%
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:
- product sales (87.7%): tools and...
Ratings of Illumina, Inc.
All news about ILLUMINA, INC.
07/05 Evercore ISI Adjusts Illumina's Price Target to $180 From $280, Maintains In Line Ratin.. MT
06/28 Community Health Network and Grail Partner to Offer Galleri® Multi-Cancer Early Detecti.. BU
06/28 Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health PR
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) added to Russell 3000 Value IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) dropped from Russell 1000 Defensive IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) dropped from Russell 1000 Growth-Defensive IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) added to Russell Top 200 Value IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) dropped from Russell 3000 Growth IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) added to Russell 3000E Value IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) dropped from Russell 3000E Growth IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) added to Russell 1000 Value IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) dropped from Russell Top 200 Growth IndexCI
06/24 ILLUMINA, INC.(NASDAQGS : ILMN) dropped from Russell 1000 Growth IndexCI
06/22 Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into t.. PR
06/22 Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into t.. CI
News in other languages on ILLUMINA, INC.
Analyst Recommendations on ILLUMINA, INC.
EU court to rule July 13 on Illumina challenge of EU review of Grail -sources
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ILLUMINA, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
193,02 $
Average target price
352,88 $
Spread / Average Target
82,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
